-
This airplane has been looked at in over seven Cost and Operational Effectiveness Analyses since its inception.
CENTERFORSECURITYPOLICY: Now Hear This: The Commandant Speaks Out on the V-22
-
Britain and Germany are pioneering comparative reviews of drugs' effectiveness and cost-benefit analyses aimed at reimbursing firms for new drugs based on how well they perform.
ECONOMIST: Developing new drugs
-
Two years ago, a panel rejected Xinlay, a prostate cancer drug from Abbott Laboratories, because the only evidence for its effectiveness came from after-the-fact analyses of two clinical trials.
FORBES: Magazine Article
-
Two years ago, a panel rejected Xinlay, a prostate cancer drug from Abbott Laboratories (nyse: ABT - news - people ), because the only evidence for its effectiveness came from after-the-fact analyses of two clinical trials.
FORBES: Dendreon Decision Could Mean FDA Shift